Pharmaceuticals: Global Industry Guide

Pharmaceuticals: Global Industry Guide

Datamonitor's Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report

* Contains an executive summary and data on value, volume and segmentation

* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).

* Includes a five-year forecast of the industry

Highlights

The global pharmaceuticals market grew by 5.5% in 2007 to reach a value of $577.2 billion.

In 2012, the market is forecast to have a value of $737.9 billion, an increase of 27.8% since 2007.

Sales of cardiovascular therapies account for 19.5% of the market by value.

The Americas is the largest pharmaceuticals market, accounting for 55% of the global market's value.

Pfizer is the leading company in the market, holding an 8.1% market share by value.

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.

For the purpose of this report the Americas comprise Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe.

Table of Contents
CHAPTER 1 Introduction 25
1.1 What is this report about? 25
1.2 Who is the target reader? 25
1.3 How to use this report 25
1.4 Definitions 26
CHAPTER 2 Global Pharmaceuticals 27
2.1 Market Overview 27
2.2 Market Value 28
2.3 Market Segmentation I 29
2.4 Market Segmentation II 30
2.5 Market Share 31
2.6 Five Forces Analysis 32
2.7 Market Forecasts 39
CHAPTER 3 Pharmaceuticals in Canada 40
3.1 Market Overview 40
3.2 Market Value 41
3.3 Market Segmentation I 42
3.4 Market Segmentation II 43
3.5 Market Share 44
3.6 Five Forces Analysis 45
3.7 Market Forecasts 52
3.8 Macroeconomic Indicators 53
CHAPTER 4 Pharmaceuticals in the United States 55
4.1 Market Overview 55
4.2 Market Value 56
4.3 Market Segmentation I 57
4.4 Market Segmentation II 58
4.5 Market Share 59
4.6 Five Forces Analysis 60
4.7 Market Forecasts 67
4.8 Macroeconomic Indicators 68
CHAPTER 5 Pharmaceuticals in China 69
5.1 Market Overview 69
5.2 Market Value 70
5.3 Market Segmentation I 71
5.4 Market Segmentation II 72
5.5 Market Share 73
5.6 Five Forces Analysis 74
5.7 Market Forecasts 80
5.8 Macroeconomic Indicators 82
CHAPTER 6 Pharmaceuticals in Japan 84
6.1 Market Overview 84
6.2 Market Value 85
6.3 Market Segmentation I 86
6.4 Market Segmentation II 87
6.5 Market Share 88
6.6 Five Forces Analysis 89
6.7 Market Forecasts 96
6.8 Macroeconomic Indicators 97
CHAPTER 7 Pharmaceuticals in Belgium 98
7.1 Market Overview 98
7.2 Market Value 99
7.3 Market Segmentation I 100
7.4 Market Segmentation II 101
7.5 Market Share 102
7.6 Five Forces Analysis 103
7.7 Market Forecasts 110
7.8 Macroeconomic Indicators 111
CHAPTER 8 Pharmaceuticals in France 113
8.1 Market Overview 113
8.2 Market Value 114
8.3 Market Segmentation I 115
8.4 Market Segmentation II 116
8.5 Market Share 117
8.6 Five Forces Analysis 118
8.7 Market Forecasts 124
8.8 Macroeconomic Indicators 125
CHAPTER 9 Pharmaceuticals in Germany 127
9.1 Market Overview 127
9.2 Market Value 128
9.3 Market Segmentation I 129
9.4 Market Segmentation II 130
9.5 Market Share 131
9.6 Five Forces Analysis 132
9.7 Market Forecasts 139
9.8 Macroeconomic Indicators 140
CHAPTER 10 Pharmaceuticals in Italy 142
10.1 Market Overview 142
10.2 Market Value 143
10.3 Market Segmentation I 144
10.4 Market Segmentation II 145
10.5 Market Share 146
10.6 Five Forces Analysis 147
10.7 Market Forecasts 154
10.8 Macroeconomic Indicators 155
CHAPTER 11 Pharmaceuticals in the Netherlands 157
11.1 Market Overview 157
11.2 Market Value 158
11.3 Market Segmentation I 159
11.4 Market Segmentation II 160
11.5 Market Share 161
11.6 Five Forces Analysis 162
11.7 Market Forecasts 169
11.8 Macroeconomic Indicators 170
CHAPTER 12 Pharmaceuticals in Spain 172
12.1 Market Overview 172
12.2 Market Value 173
12.3 Market Segmentation I 174
12.4 Market Segmentation II 175
12.5 Market Share 176
12.6 Five Forces Analysis 177
12.7 Market Forecasts 184
12.8 Macroeconomic Indicators 185
CHAPTER 13 Pharmaceuticals in the United Kingdom 187
13.1 Market Overview 187
13.2 Market Value 188
13.3 Market Segmentation I 189
13.4 Market Segmentation II 190
13.5 Market Share 191
13.6 Five Forces Analysis 192
13.7 Market Forecasts 199
13.8 Macroeconomic Indicators 200
CHAPTER 14 Pharmaceuticals in Asia-Pacific 202
14.1 Market Overview 202
14.2 Market Value 203
14.3 Market Segmentation I 204
14.4 Market Segmentation II 205
14.5 Market Share 206
14.6 Five Forces Analysis 207
14.7 Market Forecasts 214
CHAPTER 15 Pharmaceuticals in Europe 215
15.1 Market Overview 215
15.2 Market Value 216
15.3 Market Segmentation I 217
15.4 Market Segmentation II 218
15.5 Market Share 219
15.6 Five Forces Analysis 220
15.7 Market Forecasts 227
15.8 Macroeconomic Indicators 228
CHAPTER 16 COMPANY PROFILES 229
16.1 Leading Companies 229
CHAPTER 17 Appendix 242
17.1 Data Research Methodology 242
17.2 Report writing team 243


List of Tables
Table 1: Global Pharmaceuticals Market Value: $ million, 2003-2007 28
Table 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 29
Table 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 30
Table 4: Global Pharmaceuticals Market Share: % Share, by Value, 2007 31
Table 5: Global Pharmaceuticals Market Value Forecast: $ million, 2007-2012 39
Table 6: Canada Pharmaceuticals Market Value: $ million, 2003-2007 41
Table 7: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 42
Table 8: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 43
Table 9: Canada Pharmaceuticals Market Share: % Share, by Value, 2007 44
Table 10: Canada Pharmaceuticals Market Value Forecast: $ million, 2007-2012 52
Table 11: Canada Size of Population (million) , 2003-2007 53
Table 12: Canada GDP (Constant 2000 Prices, $ billion), 2003-2007 53
Table 13: Canada Inflation, 2003-2007 53
Table 14: Canada Exchange Rate, 2003-2007 54
Table 15: United States Pharmaceuticals Market Value: $ million, 2003-2007 56
Table 16: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 57
Table 17: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 58
Table 18: United States Pharmaceuticals Market Share: % Share, by Value, 2007 59
Table 19: United States Pharmaceuticals Market Value Forecast: $ million, 2007-2012 67
Table 20: United States Size of Population (million) , 2003-2007 68
Table 21: United States GDP (Constant 2000 Prices, $ billion), 2003-2007 68
Table 22: United States Inflation, 2003-2007 68
Table 23: China Pharmaceuticals Market Value: $ million, 2003-2007 70
Table 24: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 71
Table 25: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 72
Table 26: China Pharmaceuticals Market Share: % Share, by Value, 2007 73
Table 27: China Pharmaceuticals Market Value Forecast: $ million, 2007-2012 80
Table 28: China Size of Population (million) , 2003-2007 82
Table 29: China GDP (Constant 2000 Prices, $ billion), 2003-2007 82
Table 30: China Inflation, 2003-2007 82
Table 31: China Exchange Rate, 2003-2007 83
Table 32: Japan Pharmaceuticals Market Value: $ million, 2003-2007 85
Table 33: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 86
Table 34: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 87
Table 35: Japan Pharmaceuticals Market Share: % Share, by Value, 2007 88
Table 36: Japan Pharmaceuticals Market Value Forecast: $ million, 2007-2012 96
Table 37: Japan Size of Population (million) , 2003-2007 97
Table 38: Japan GDP (Constant 2000 Prices, $ billion), 2003-2007 97
Table 39: Japan Exchange Rate, 2003-2007 97
Table 40: Belgium Pharmaceuticals Market Value: $ million, 2003-2007 99
Table 41: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 100
Table 42: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 101
Table 43: Belgium Pharmaceuticals Market Share: % Share, by Value, 2007 102
Table 44: Belgium Pharmaceuticals Market Value Forecast: $ million, 2007-2012 110
Table 45: Belgium Size of Population (million) , 2003-2007 111
Table 46: Belgium GDP (Constant 2000 Prices, $ billion), 2003-2007 111
Table 47: Belgium Inflation, 2003-2007 111
Table 48: Belgium Exchange Rate, 2003-2007 112
Table 49: France Pharmaceuticals Market Value: $ million, 2003-2007 114
Table 50: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 115
Table 51: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 116
Table 52: France Pharmaceuticals Market Share: % Share, by Value, 2007 117
Table 53: France Pharmaceuticals Market Value Forecast: $ million, 2007-2012 124
Table 54: France Size of Population (million) , 2003-2007 125
Table 55: France GDP (Constant 2000 Prices, $ billion), 2003-2007 125
Table 56: France Inflation, 2003-2007 125
Table 57: France Exchange Rate, 2003-2007 126
Table 58: Germany Pharmaceuticals Market Value: $ million, 2003-2007 128
Table 59: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 129
Table 60: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 130
Table 61: Germany Pharmaceuticals Market Share: % Share, by Value, 2007 131
Table 62: Germany Pharmaceuticals Market Value Forecast: $ million, 2007-2012 139
Table 63: Germany Size of Population (million) , 2003-2007 140
Table 64: Germany GDP (Constant 2000 Prices, $ billion), 2003-2007 140
Table 65: Germany Inflation, 2003-2007 140
Table 66: Germany Exchange Rate, 2003-2007 141
Table 67: Italy Pharmaceuticals Market Value: $ million, 2003-2007 143
Table 68: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 144
Table 69: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 145
Table 70: Italy Pharmaceuticals Market Share: % Share, by Value, 2007 146
Table 71: Italy Pharmaceuticals Market Value Forecast: $ million, 2007-2012 154
Table 72: Italy Size of Population (million) , 2003-2007 155
Table 73: Italy GDP (Constant 2000 Prices, $ billion), 2003-2007 155
Table 74: Italy Inflation, 2003-2007 155
Table 75: Italy Exchange Rate, 2003 156
Table 76: Netherlands Pharmaceuticals Market Value: $ million, 2003-2007 158
Table 77: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 159
Table 78: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 160
Table 79: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2007 161
Table 80: Netherlands Pharmaceuticals Market Value Forecast: $ million, 2007-2012 169
Table 81: Netherlands Size of Population (million) , 2003-2007 170
Table 82: Netherlands GDP (Constant 2000 Prices, $ billion), 2003-2007 170
Table 83: Netherlands Inflation, 2003-2007 170
Table 84: Netherlands Exchange Rate, 2003-2007 171
Table 85: Spain Pharmaceuticals Market Value: $ million, 2003-2007 173
Table 86: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 174
Table 87: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 175
Table 88: Spain Pharmaceuticals Market Share: % Share, by Value, 2007 176
Table 89: Spain Pharmaceuticals Market Value Forecast: $ million, 2007-2012 184
Table 90: Spain Size of Population (million) , 2003-2007 185
Table 91: Spain GDP (Constant 2000 Prices, $ billion), 2003-2007 185
Table 92: Spain Inflation, 2003-2007 185
Table 93: Spain Exchange Rate, 2003-2007 186
Table 94: United Kingdom Pharmaceuticals Market Value: $ million, 2003-2007 188
Table 95: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 189
Table 96: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 190
Table 97: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2007 191
Table 98: United Kingdom Pharmaceuticals Market Value Forecast: $ million, 2007-2012 199
Table 99: United Kingdom Size of Population (million) , 2003-2007 200
Table 100: United Kingdom GDP (Constant 2000 Prices, $ billion), 2003-2007 200
Table 101: United Kingdom Inflation, 2003-2007 200
Table 102: United Kingdom Exchange Rate, 2003-2007 201
Table 103: Asia-Pacific Pharmaceuticals Market Value: $ million, 2003-2007 203
Table 104: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 204
Table 105: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 205
Table 106: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2007 206
Table 107: Asia-Pacific Pharmaceuticals Market Value Forecast: $ million, 2007-2012 214
Table 108: Europe Pharmaceuticals Market Value: $ million, 2003-2007 216
Table 109: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 217
Table 110: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 218
Table 111: Europe Pharmaceuticals Market Share: % Share, by Value, 2007 219
Table 112: Europe Pharmaceuticals Market Value Forecast: $ million, 2007-2012 227
Table 113: Europe Exchange Rate, 2003-2007 228
Table 114: Key Facts: Pfizer Inc 229
Table 115: Key Financials: Pfizer Inc 231
Table 116: Key Facts: GlaxoSmithKline Plc 232
Table 117: Key Financials: GlaxoSmithKline Plc 235
Table 118: Key Facts: Johnson & Johnson 236
Table 119: Key Financials: Johnson & Johnson 238
Table 120: Key Facts: Merck & Co., Inc. 239
Table 121: Key Financials: Merck & Co., Inc. 241


List of Figures
Figure 1: Global Pharmaceuticals Market Value: $ million, 2003-2007 28
Figure 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 29
Figure 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 30
Figure 4: Global Pharmaceuticals Market Share: % Share, by Value, 2007 31
Figure 5: Forces Driving Competition in the Global Pharmaceuticals Market, 2007 32
Figure 6: Drivers of Buyer Power in the Global Pharmaceuticals Market, 2007 33
Figure 7: Drivers of Supplier Power in the Global Pharmaceuticals Market, 2007 34
Figure 8: Factors Influencing the Likelihood of New Entrants in the Global Pharmaceuticals Market, 2007 36
Figure 9: Factors Influencing the Threat of Substitutes in the Global Pharmaceuticals Market, 2007 37
Figure 10: Drivers of Degree of Rivalry in the Global Pharmaceuticals Market, 2007 38
Figure 11: Global Pharmaceuticals Market Value Forecast: $ million, 2007-2012 39
Figure 12: Canada Pharmaceuticals Market Value: $ million, 2003-2007 41
Figure 13: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 42
Figure 14: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 43
Figure 15: Canada Pharmaceuticals Market Share: % Share, by Value, 2007 44
Figure 16: Forces Driving Competition in the Pharmaceuticals Market in Canada, 2007 45
Figure 17: Drivers of Buyer Power in the Pharmaceuticals Market in Canada, 2007 46
Figure 18: Drivers of Supplier Power in the Pharmaceuticals Market in Canada, 2007 47
Figure 19: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Canada, 2007 48
Figure 20: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Canada, 2007 49
Figure 21: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Canada, 2007 50
Figure 22: Canada Pharmaceuticals Market Value Forecast: $ million, 2007-2012 52
Figure 23: United States Pharmaceuticals Market Value: $ million, 2003-2007 56
Figure 24: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 57
Figure 25: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 58
Figure 26: United States Pharmaceuticals Market Share: % Share, by Value, 2007 59
Figure 27: Forces Driving Competition in the Pharmaceuticals Market in the US, 2007 60
Figure 28: Drivers of Buyer Power in the Pharmaceuticals Market in the US, 2007 61
Figure 29: Drivers of Supplier Power in the Pharmaceuticals Market in the US, 2007 62
Figure 30: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the US, 2007 64
Figure 31: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the US, 2007 65
Figure 32: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the US, 2007 66
Figure 33: United States Pharmaceuticals Market Value Forecast: $ million, 2007-2012 67
Figure 34: China Pharmaceuticals Market Value: $ million, 2003-2007 70
Figure 35: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 71
Figure 36: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 72
Figure 37: China Pharmaceuticals Market Share: % Share, by Value, 2007 73
Figure 38: Forces Driving Competition in the Pharmaceuticals Market in China, 2007 74
Figure 39: Drivers of Buyer Power in the Pharmaceuticals Market in China, 2007 75
Figure 40: Drivers of Supplier Power in the Pharmaceuticals Market in China, 2007 76
Figure 41: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in China, 2007 77
Figure 42: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in China, 2007 78
Figure 43: Drivers of Degree of Rivalry in the Pharmaceuticals Market in China, 2007 79
Figure 44: hina Pharmaceuticals Market Value Forecast: $ million, 2007-2012 81
Figure 45: Japan Pharmaceuticals Market Value: $ million, 2003-2007 85
Figure 46: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 86
Figure 47: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 87
Figure 48: Japan Pharmaceuticals Market Share: % Share, by Value, 2007 88
Figure 49: Forces Driving Competition in the Pharmaceuticals Market in Japan, 2007 89
Figure 50: Drivers of Buyer Power in the Pharmaceuticals Market in Japan, 2007 90
Figure 51: Drivers of Supplier Power in the Pharmaceuticals Market in Japan, 2007 91
Figure 52: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Japan, 2007 92
Figure 53: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Japan, 2007 93
Figure 54: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Japan, 2007 94
Figure 55: Japan Pharmaceuticals Market Value Forecast: $ million, 2007-2012 96
Figure 56: Belgium Pharmaceuticals Market Value: $ million, 2003-2007 99
Figure 57: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 100
Figure 58: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 101
Figure 59: Belgium Pharmaceuticals Market Share: % Share, by Value, 2007 102
Figure 60: Forces Driving Competition in the Pharmaceuticals Market in Belgium, 2007 103
Figure 61: Drivers of Buyer Power in the Pharmaceuticals Market in Belgium, 2007 104
Figure 62: Drivers of Supplier Power in the Pharmaceuticals Market in Belgium, 2007 105
Figure 63: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Belgium, 2007 106
Figure 64: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Belgium, 2007 107
Figure 65: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Belgium, 2007 108
Figure 66: Belgium Pharmaceuticals Market Value Forecast: $ million, 2007-2012 110
Figure 67: France Pharmaceuticals Market Value: $ million, 2003-2007 114
Figure 68: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 115
Figure 69: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 116
Figure 70: France Pharmaceuticals Market Share: % Share, by Value, 2007 117
Figure 71: Forces Driving Competition in the Pharmaceuticals Market in France, 2007 118
Figure 72: Drivers of Buyer Power in the Pharmaceuticals Market in France, 2007 119
Figure 73: Drivers of Supplier Power in the Pharmaceuticals Market in France, 2007 120
Figure 74: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in France, 2007 121
Figure 75: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in France, 2007 122
Figure 76: Drivers of Degree of Rivalry in the Pharmaceuticals Market in France, 2007 123
Figure 77: France Pharmaceuticals Market Value Forecast: $ million, 2007-2012 124
Figure 78: Germany Pharmaceuticals Market Value: $ million, 2003-2007 128
Figure 79: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 129
Figure 80: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 130
Figure 81: Germany Pharmaceuticals Market Share: % Share, by Value, 2007 131
Figure 82: Forces Driving Competition in the Pharmaceuticals Market in Germany, 2007 132
Figure 83: Drivers of Buyer Power in the Pharmaceuticals Market in Germany, 2007 133
Figure 84: Drivers of Supplier Power in the Pharmaceuticals Market in Germany, 2007 134
Figure 85: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Germany, 2007 135
Figure 86: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Germany, 2007 136
Figure 87: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Germany, 2007 137
Figure 88: Germany Pharmaceuticals Market Value Forecast: $ million, 2007-2012 139
Figure 89: Italy Pharmaceuticals Market Value: $ million, 2003-2007 143
Figure 90: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 144
Figure 91: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 145
Figure 92: Italy Pharmaceuticals Market Share: % Share, by Value, 2007 146
Figure 93: Forces Driving Competition in the Pharmaceuticals Market in Italy, 2007 147
Figure 94: Drivers of Buyer Power in the Pharmaceuticals Market in Italy, 2007 148
Figure 95: Drivers of Supplier Power in the Pharmaceuticals Market in Italy, 2007 149
Figure 96: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Italy, 2007 150
Figure 97: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Italy, 2007 151
Figure 98: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Italy, 2007 152
Figure 99: Italy Pharmaceuticals Market Value Forecast: $ million, 2007-2012 154
Figure 100: Netherlands Pharmaceuticals Market Value: $ million, 2003-2007 158
Figure 101: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 159
Figure 102: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 160
Figure 103: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2007 161
Figure 104: Forces Driving Competition in the Pharmaceuticals Market in the Netherlands, 2007 162
Figure 105: Drivers of Buyer Power in the Pharmaceuticals Market in the Netherlands, 2007 163
Figure 106: Drivers of Supplier Power in the Pharmaceuticals Market in the Netherlands, 2007 164
Figure 107: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the Netherlands, 2007 165
Figure 108: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the Netherlands, 2007 166
Figure 109: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the Netherlands, 2007 167
Figure 110: Netherlands Pharmaceuticals Market Value Forecast: $ million, 2007-2012 169
Figure 111: Spain Pharmaceuticals Market Value: $ million, 2003-2007 173
Figure 112: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 174
Figure 113: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 175
Figure 114: Spain Pharmaceuticals Market Share: % Share, by Value, 2007 176
Figure 115: Forces Driving Competition in the Pharmaceuticals Market in Spain, 2007 177
Figure 116: Drivers of Buyer Power in the Pharmaceuticals Market in Spain, 2007 178
Figure 117: Drivers of Supplier Power in the Pharmaceuticals Market in Spain, 2007 179
Figure 118: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Spain, 2007 180
Figure 119: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Spain, 2007 182
Figure 120: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Spain, 2007 183
Figure 121: Spain Pharmaceuticals Market Value Forecast: $ million, 2007-2012 184
Figure 122: United Kingdom Pharmaceuticals Market Value: $ million, 2003-2007 188
Figure 123: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 189
Figure 124: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 190
Figure 125: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2007 191
Figure 126: Forces Driving Competition in the Pharmaceuticals Market in the United Kingdom, 2007 192
Figure 127: Drivers of Buyer Power in the Pharmaceuticals Market in the United Kingdom, 2007 193
Figure 128: Drivers of Supplier Power in the Pharmaceuticals Market in the United Kingdom, 2007 194
Figure 129: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the United Kingdom, 2007 196
Figure 130: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the United Kingdom, 2007 197
Figure 131: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the United Kingdom, 2007 198
Figure 132: United Kingdom Pharmaceuticals Market Value Forecast: $ million, 2007-2012 199
Figure 133: Asia-Pacific Pharmaceuticals Market Value: $ million, 2003-2007 203
Figure 134: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 204
Figure 135: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 205
Figure 136: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2007 206
Figure 137: Forces Driving Competition in the Pharmaceuticals Market in Asia-Pacific, 2007 207
Figure 138: Drivers of Buyer Power in the Pharmaceuticals Market in Asia-Pacific, 2007 208
Figure 139: Drivers of Supplier Power in the Pharmaceuticals Market in Asia-Pacific, 2007 209
Figure 140: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Asia-Pacific, 2007 211
Figure 141: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Asia-Pacific, 2007 212
Figure 142: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Asia-Pacific, 2007 213
Figure 143: Asia-Pacific Pharmaceuticals Market Value Forecast: $ million, 2007-2012 214
Figure 144: Europe Pharmaceuticals Market Value: $ million, 2003-2007 216
Figure 145: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 217
Figure 146: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 218
Figure 147: Europe Pharmaceuticals Market Share: % Share, by Value, 2007 219
Figure 148: Forces Driving Competition in the Pharmaceuticals Market in Europe, 2007 220
Figure 149: Drivers of Buyer Power in the Pharmaceuticals Market in Europe, 2007 221
Figure 150: Drivers of Supplier Power in the Pharmaceuticals Market in Europe, 2007 222
Figure 151: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Europe, 2007 224
Figure 152: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Europe, 2007 225
Figure 153: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Europe, 2007 226
Figure 154: Europe Pharmaceuticals Market Value Forecast: $ million, 2007-2012 227
Figure 155: Revenues & Profitability: Pfizer Inc 231
Figure 156: Revenues & Profitability: GlaxoSmithKline Plc 235
Figure 157: Revenues & Profitability: Johnson & Johnson 238
Figure 158: Revenues & Profitability: Merck & Co., Inc. 241